+49 (0) 2921 66687-0 cyberknife@dzsp.de

About the treatment of

Kidney diseases

Treatment of kidney disease

The treatment of kidney diseases, especially renal cell carcinoma, has made considerable progress in recent years. One advanced technology that has proven to be extremely effective is the CyberKnife® system. In this text, we will take an in-depth look at the treatment of renal cell carcinoma using CyberKnife® technology.

Renal cell carcinoma is the most common form of kidney cancer and occurs when malignant cells grow in the kidneys. Treatment for renal cell carcinoma depends on several factors, including the size and stage of the tumor and the presence of metastases. CyberKnife® technology offers a promising solution for the treatment of renal cell carcinoma.

Indication kidney diseases

• Kidney tumors
• Adrenal tumors

The treatment of renal carcinoma

The treatment of renal cell carcinoma with CyberKnife® offers several advantages. First, precise radiotherapy allows for higher dose delivery to the tumor, resulting in more effective tumor destruction. Second, the treatment is non-invasive, meaning no surgery is required. This reduces the risk of complications and significantly reduces recovery time. Third, CyberKnife® enables a shorter treatment time compared to conventional radiation methods. In most cases, only a few sessions are required, usually within a week or two. The treatment of renal cell carcinoma with CyberKnife® usually takes place in a series of outpatient sessions. Before starting treatment, detailed diagnostic imaging is performed to determine the exact location of the tumor. This enables the beam of rays to be precisely aimed at the tumor during treatment. During the session, the patient lies on a special treatment table connected to the CyberKnife® system. The robotic arm of the CyberKnife® system moves precisely around the patient to direct the beam of radiation onto the tumor from different angles. The patient usually does not feel any pain during the treatment.

However, it should be noted that the decision to undergo treatment with CyberKnife® for renal cell carcinoma depends on various factors. It is important that patients consult with a radiotherapy specialist to receive a comprehensive assessment of their individual case and determine the best possible treatment option.

The conclusion

The treatment of renal cell carcinoma with the CyberKnife® technology has shown promise. Precise and gentle radiation therapy enables effective tumor reduction and improves the patient’s quality of life. It is important that patients consult with their doctor about their individual situation and weigh the pros and cons of CyberKnife® treatment.

Contact us

Feel free to contact us using the contact form
or reach us by phone.

+49 (0) 2921 66687 20

data protection

10 + 1 =

Contact

DEUTSCHES CYBERKNIFE ZENTRUM

Deutsches Zentrum für Stereotaxie
und Präzisionsbestrahlung GmbH

Senator-Schwartz-Ring 8
59494 Soest

Phone : +49 (0) 2921 66687 20
Fax: +49 (0) 2921 66687 22
Mail general: info@dzsp.de

Mail patient request: cyberknife@dzsp.de

© 2023 Deutsches CyberKnife Zentrum